SKWD has dropped 6.5% on the week to $58.36, surrendering a chunk of last month's 17% surge — yet the short base is simultaneously unwinding, creating an unusual divergence heading into the July 31 earnings print.
The most striking data point right now is what shorts are doing with that pullback: not pressing it. Short interest has fallen 15% over the past week to around 5% of free float, reversing a build that had nearly doubled from mid-June into early July. That unwind matters more when you note the borrow market offers almost no resistance — availability is running at 1,270%, meaning lenders hold roughly twelve shares for every one currently out on loan, and the cost to borrow has eased to just 0.47%. This is not a market where squeeze pressure is building. If anything, the short retreat looks like profit-taking after a well-timed trade against last month's rally, rather than a structural capitulation. Options traders echo that relatively relaxed tone: the put/call ratio has dropped to 0.64, more than one standard deviation below its 20-day average of 0.98, suggesting call activity is actually outpacing puts even as the stock slides — a mildly bullish lean in the options market that cuts against the bearish price action.
The Street's posture is clear and has become more so this week. Piper Sandler raised its target again today — to $72 from $68, maintaining Overweight — just days after KBW lifted to $72 and Barclays to $65. All three moves came within the past eight days, and all maintained positive ratings. The consensus mean target is now around $62.90, which sits above the current price of $58.36, giving approximately 8% upside to that level. As the prior note observed, the Street spent April cutting targets into tariff-driven weakness and has spent the past three months reversing course with equal conviction. Bulls are anchored in disciplined underwriting, the Apollo Group acquisition, and specialty market positioning. The bear case — catastrophe exposure, ESG and regulatory risk, softening investment income — has not gone away, but the unanimous direction of recent analyst moves tells you where the weight of professional opinion currently rests. Factor scores are moderate: EPS surprise ranks in the 60th percentile, EPS momentum over 90 days sits at the 63rd, and the short score of 43 has eased from above 47 earlier in the month, consistent with the unwinding short base.
Institutional ownership provides a stabilising backdrop. BlackRock holds 8.2% and added over 500,000 shares in the most recent reported period. T. Rowe Price added more than 826,000 shares to reach nearly 5%. Wasatch Advisors added 635,000 shares, reaching a 2.4% stake. The pattern across the top holders is broadly additive — not a single major name among the recently reported changes is cutting. That kind of institutional accumulation into a name that spent part of Q2 under pressure suggests conviction buyers stepped in during the dip, even if the stock hasn't fully rewarded them yet.
The week's price action is worth contextualising against peers. PLMR, SKWD's most closely correlated peer, fell 6.3% over the same period — almost identically to SKWD's 6.5% drop — suggesting sector-wide pressure rather than a company-specific story. EG and RYAN held in far better, each down less than 1% on the week, pointing to some dispersion within insurance that didn't fully spare SKWD or PLMR.
The next focus is July 31. Recent earnings history has been constructive: the last two prints each produced positive next-day moves of 3.6% and 6.5%, with the five-day follow-through positive in both cases. Whether the Street's freshly lifted targets and the easing short base create a similar setup depends entirely on what the Q2 underwriting numbers say about catastrophe experience and premium growth — that's the binary the market is pricing into a put/call ratio that, for now, still leans bullish.
See the live data behind this article on ORTEX.
Open SKWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
